
FDA Set to Discuss Risks and Benefits of Metal-on-Metal Hip Replacements
An FDA advisory group will thoroughly investigate the pros and risks associated with controversial metal-on-metal hip implants June 27 and 28.
An FDA advisory group will thoroughly investigate the pros and risks associated with controversial metal-on-metal hip implants June 27 and 28.
The NJ-based pharmaceutical giant has reserved $600 million to potentially settle lawsuits alleging the company paid Omnicare to buy more lots of schizophrenia drugs.
Corrosion issues in Chrysler's Jeep Liberty's SUVs has lead to a recall.
Due to the life threatening results of patients consuming Praxada, a motion has been filed to consolidate future lawsuits against it.
The letter sent to the court notifying of Ethicon's decision to withdraw four Gynecare vaginal meshes from the market.
Johnson & Johnson have stated that they will stop producing vaginal mesh products.
U.S. District Judge Lucy Koh has certified a lawsuit against JP Morgan Chase and Washington Mutual for allegedly reducing the credit limits on their home equity lines of
A Pradaxa RE-LY study was conducted prior to FDA approval, but critics claimed it was flawed.
U.S. Bank is the target of a new potential class action lawsuit that alleges the company forced placed flood insurance on mortgage holders in illegal amounts and through
DePuy's compensation packets are not enough for clients facing large medical bills and medications.